Artificial intelligence is now autonomously designing entirely new medicines
AI systems are now bypassing years of traditional laboratory trial and error by autonomously engineering novel molecular structures to treat diseases that have long frustrated human researchers.
Advanced AI platforms are revolutionizing pharmacology by dreaming up entirely new drug molecules that do not exist in nature. In 2023, the first drug discovered and designed by generative AI reached Phase II clinical trials for treating idiopathic pulmonary fibrosis. These systems can analyze millions of biological interactions in seconds to predict which chemical structures will effectively bind to specific disease targets.
There's more to this story — open the app to keep reading.
Continue Reading in App
1 more paragraphs · plus a 2-question quiz